🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07581665
Starting soon Phase 4

Effective Dose of Alfentanil Combined With Propofol for Laryngeal Mask Airway Insertion in Children

NCT07581665 · tracked via the Priya Life Science China tracker
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase
Phase 4
Started
2026-05-01
Last updated
2026-05-12

Condition(s) studied

Pediatric AnesthesiaAirway ManagementGeneral AnesthesiaLMA

Investigational drug(s) / intervention(s)

Alfentanil

Alfentanil: All patients receive 2.5 mg/kg propofol injected over 30 seconds. Alfentanil is administered 1 minute prior to propofol. The dose is adjusted by steps of 2 µg/kg based on the previous patient's response (successful insertion = decrease dose; failed insertion = increase dose).

Study summary

This study uses a prospective, up-and-down sequential allocation method to determine the median effective dose (ED50) and 95% effective dose (ED95) of alfentanil combined with propofol for successful laryngeal mask airway (LMA) insertion in children aged 7-12 undergoing elective day surgery.

Eligibility

Sex
ALL
Min age
7 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 7 to 12 years * Undergoing elective day surgery * ASA physical status I-II * Body Mass Index (BMI) between 14 and 24 kg/m² * Accompanied by a fully capable guardian within 24 hours after discharge Exclusion Criteria: * Allergy to opioids * Unresolved upper respiratory tract infection within the past 1 week * Abnormal heart, lung, liver, or kidney function, or metabolic diseases * Airway anatomical abnormalities (e.g., micrognathia, laryngomalacia, macroglossia) or OSAHS (Obstructive Sleep Apnea-Hypopnea Syndrome) * Use of analgesics, sedatives, or other psychotropic drugs within the past 2 weeks * Refusal to sign the informed consent form

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Anesthesiology, Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou Guangdong

More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07581665 on ClinicalTrials.gov ↗ ← All trials in China